Failure to Meet Plans and Impairment Following Acquisitions, Subsidiary Establishments and Investments
First written in FY2017. 10 of 19 entries say "Restated". Latest entry: FY2025.
Broadleaf moved to the "Worse" side of this theme in 2025, 3 years after the typical company in this theme (2022).
The whole theme swung hardest in 2017: 9 of 15 companies on the "Worse" side.
19 other companies' latest entry also says "Materialised".
- FY2025MaterialisedAnnual report
「Losses on valuation of shares in affiliated companies comprised ¥645.696 million on shares of SALES GO株式会社 and ¥95.076 million on shares of Zenmov株式会社.」
As the value of investee assets declined, the company recorded losses on valuation of shares in affiliated companies relating to SALES GO and Zenmov, and the risk of a decline in value after investment materialized again. - FY2025-H1MaterialisedAnnual report
「In addition, during the current interim consolidated accounting period, the company conducted impairment accounting for shares in an equity-method affiliate.」
The company conducted impairment accounting for its investment in an equity-method affiliate. Investments accounted for under the equity method fell from ¥95 million at the end of the previous fiscal year to zero, and an equity-method investment loss of ¥95 million was recorded. The risk of a decline in asset value after an acquisition or investment materialized again. - FY2024MaterialisedAnnual report
「Losses on valuation of shares in affiliated companies comprised ¥189.187 million on shares of 株式会社タジマ, ¥105.550 million on shares of Zenmov株式会社 and ¥44.421 million on shares of Broadleaf I.T. Solutions Inc.」
As the value of investee assets declined, the company recorded losses on valuation of shares in affiliated companies for タジマ, Zenmov and Broadleaf I.T. Solutions. - FY2024-H1RestatedAnnual report
「During the interim consolidated accounting period, there were no new business or other risks, nor any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company stated that there had been no material changes in the risks associated with acquisitions, the establishment of subsidiaries, failure to meet post-investment plans and impairment. - FY2024-Q1RestatedAnnual report
「During the cumulative period of the first quarter of the consolidated fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company stated that there had been no material changes in the risks associated with acquisitions, the establishment of subsidiaries, failure to meet post-investment plans and impairment. - FY2023MaterialisedAnnual report
「Arising from the 2019 business combination involving 株式会社産業革新研究所 (¥63.464 million at the end of the previous fiscal year; nil at the end of the current fiscal year)」
Goodwill of ¥63.464 million arising from the business combination involving 産業革新研究所 was eliminated through impairment during the year, and the risk of a decline in asset value and impairment after an acquisition materialized. - FY2023-Q3RestatedAnnual report
「During the nine-month period ended in the third quarter, there were no new business or other risks, and no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company stated that there had been no material changes in the risks associated with acquisitions, the establishment of subsidiaries, failure to meet post-investment plans and impairment. - FY2023-Q1RestatedAnnual report
「During the cumulative period of the first quarter of the consolidated fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company stated that there had been no material changes in the risks associated with acquisitions, the establishment of subsidiaries, failure to meet post-investment plans and impairment. - FY2022-Q3RestatedAnnual report
「During the nine-month period ended in the third quarter, there were no new business or other risks, and no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company stated that there had been no material changes in the risks associated with acquisitions, the establishment of subsidiaries, failure to meet post-investment plans and impairment. - FY2022-Q2RestatedAnnual report
「During the cumulative second quarter of the consolidated fiscal year, there were no new business or other risks and no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company stated that there had been no material changes in the risks associated with acquisitions, the establishment of subsidiaries, failure to meet post-investment plans and impairment. - FY2021-Q3RestatedAnnual report
「Although the spread of COVID-19 continues, it has not had a material impact on the current-period results of the Group. If the impact of COVID-19 were to persist or expand beyond expectations, it could affect significant accounting estimates and judgments, including impairment testing of goodwill.」
While stating that COVID-19 had not had a material impact on current-period results at this point, the company continued to disclose that a prolonged or expanded impact could affect impairment testing of goodwill and other matters. - FY2021-Q2RestatedAnnual report
「Although the spread of COVID-19 continues, it has not had a material impact on the current-period results of the Group. If the impact of COVID-19 were to persist or expand beyond expectations, it could affect significant accounting estimates and judgments, including impairment testing of goodwill.」
While stating that there had been no material impact on current-period results at this point, the company continued to disclose that a prolonged or expanded impact of COVID-19 could affect impairment testing of goodwill and other matters. - FY2021-Q1Current impact on results remains limited, while potential impairment risk continuesAnnual report
「Although the spread of COVID-19 continues, it has not had a material impact on the current-period results of the Group. If the impact of COVID-19 were to persist or expand beyond expectations, it could affect significant accounting estimates and judgments, including impairment testing of goodwill.」
While stating that there had been no material impact on current-period results at this point, the company continued to disclose that a prolonged or expanded impact of COVID-19 could affect impairment testing of goodwill and other matters. - FY2020-Q3RestatedAnnual report
「From the end of the third quarter of the fiscal year onward, if the impact of COVID-19 were to persist or expand beyond expectations, it could affect significant accounting estimates and judgments, including impairment testing of goodwill.」
The company continued to disclose that the prolonged or expanded impact of COVID-19 could affect accounting estimates and judgments, including impairment testing of goodwill arising from acquisitions. quantified=false, materialized=false. - FY2020-Q2WorsenedAnnual report
「From the second half onward, if the impact of COVID-19 were to persist or expand beyond expectations, it could affect significant accounting estimates and judgments, including impairment testing of goodwill.」
The company added a disclosure that the prolonged or expanded impact of COVID-19 could affect significant accounting estimates and judgments, including impairment testing of goodwill. - FY2019MitigatedAnnual report
「For 株式会社タジマ, as of the end of the fiscal year, the recoverable amount exceeds the carrying amount by ¥560.422 million; however, if the discount rate were to rise by 4.1% or the growth rate were to decline by 1.8%, the carrying amount would exceed the recoverable amount.」
For タジマ's goodwill, the headroom between the recoverable amount and carrying amount increased from ¥159.132 million to ¥560.422 million, while the sensitivity threshold for impairment widened from a 2.0% increase in the discount rate and a 0.9% decrease in the growth rate to 4.1% and 1.8%, respectively. - FY2019-Q3RestatedAnnual report
「During the nine-month period ended in the third quarter, there were no new business or other risks, and no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company stated that there had been no material changes in the risks associated with acquisitions, the establishment of subsidiaries, failure to meet post-investment plans and impairment. - FY2018WorsenedAnnual report
「For 株式会社タジマ, as of the end of the fiscal year, the recoverable amount exceeds the carrying amount by ¥159.132 million; however, if the discount rate were to rise by 2.0% or the growth rate were to decline by 0.9%, the carrying amount would exceed the recoverable amount.」
The headroom before impairment and sensitivity of the goodwill arising from the acquisition of タジマ were quantified. The permissible range for changes in the discount rate and growth rate is narrower than in the previous fiscal year, and the impairment risk has been quantified more specifically. - FY2017First statedAnnual report
「If the businesses receiving the Group's investments or loans do not progress as planned, or if the Group is unable to use its management resources efficiently, this may affect the Group's performance and financial condition.」
Disclosed the possibility of failing to meet plans, inefficient use of resources, declines in asset values, impairment losses and losses on disposal in connection with acquisitions, establishment of subsidiaries, joint ventures and alliance investments.